Khiron Life Sciences Corp.
KHRNF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $22 | $22 | $45 | $37 |
| - Cash | $2 | $6 | $5 | $9 |
| + Debt | $3 | $2 | $3 | $2 |
| Enterprise Value | $22 | $19 | $43 | $31 |
| Revenue | $3 | $4 | $5 | $4 |
| % Growth | -24.3% | -3.7% | 27.7% | – |
| Gross Profit | $2 | $2 | $1 | $1 |
| % Margin | 48.8% | 52.6% | 32.2% | 32.2% |
| EBITDA | -$3 | -$3 | -$5 | -$3 |
| % Margin | -85.3% | -56.3% | -99.3% | -81.4% |
| Net Income | -$4 | -$2 | -$5 | -$20 |
| % Margin | -105.6% | -48.5% | -116.6% | -536.3% |
| EPS Diluted | -0.017 | -0.012 | -0.03 | -0.11 |
| % Growth | -44% | 61.6% | 72.5% | – |
| Operating Cash Flow | -$5 | -$2 | -$3 | -$5 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$6 | -$2 | -$3 | -$6 |